The availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for patients and the health-care system, the federal agency said in a news release Monday
In December, the FDA declared that Eli Lilly's weight loss and diabetes medication tirzepatide, sold under the brand names Mounjaro and Zepbound, was no longer in short supply
Similar findings were reported for glucagon/GLP-1 dual agonists, where increased fatty acid oxidation in white adipose tissue contributes significantly to energy expenditure [32, 33]
But this year, the American Journal of Clinical Nutrition released dietary guidelines to consider when prescribing and using GLP-1s
The way it works is that microscopic needles deliver a steady stream of medicineequivalent to a once-daily injectable doseinto the bloodstream or into the dermal fluid, she explains